HIV Clinical Trials in Dallas, Texas
8 recruitingDallas, Texas
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
HIV Infections
ViiV Healthcare332 enrolled89 locationsNCT06694805
Recruiting
Phase 2Phase 3
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Merck Sharp & Dohme LLC570 enrolled24 locationsNCT07266831
Recruiting
Not Applicable
HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy
HIVPrEPIncarceration
University of Texas Southwestern Medical Center3,600 enrolled1 locationNCT06919419
Recruiting
Not Applicable
HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
HIV InfectionAdvanced End Stage Heart Failure
University of Texas Southwestern Medical Center50 enrolled1 locationNCT06659952
Recruiting
The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services
HIV PreventionHIV Disease
University of Texas Southwestern Medical Center100 enrolled1 locationNCT07292792
Recruiting
Phase 1
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
HIV Infections
ViiV Healthcare100 enrolled41 locationsNCT07053384
Recruiting
Phase 2
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Acute HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)48 enrolled36 locationsNCT05719441
Recruiting
Phase 1Phase 2
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
High-grade B-cell LymphomaNon-Hodgkin LymphomaLymphoma+12 more
Estrella Biopharma, Inc.21 enrolled2 locationsNCT06343311